Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Neurobiol Aging ; 109: 64-77, 2022 01.
Article in English | MEDLINE | ID: mdl-34655982

ABSTRACT

In Alzheimer disease, Tau pathology is thought to propagate from cell to cell throughout interconnected brain areas. However, the forms of Tau released into the brain interstitial fluid (ISF) in vivo during the development of Tauopathy and their pathological relevance remain unclear. Combining in vivo microdialysis and biochemical analysis, we find that in Tau transgenic mice, human Tau (hTau) present in brain ISF is truncated and comprises at least 10 distinct fragments spanning the entire Tau protein. The fragmentation pattern is similar across different Tau transgenic models, pathological stages and brain areas. ISF hTau concentration decreases during Tauopathy progression, while its phosphorylation increases. ISF from mice with established Tauopathy induces Tau aggregation in HEK293-Tau biosensor cells. Notably, immunodepletion of ISF phosphorylated Tau, but not Tau fragments, significantly reduces its ability to seed Tau aggregation and only a fraction of Tau, separated by ultracentrifugation, is seeding-competent. These results indicate that ISF seeding competence is driven by a small subset of Tau, which potentially contribute to the propagation of Tau pathology.


Subject(s)
Brain/metabolism , Extracellular Fluid/metabolism , Tauopathies/metabolism , tau Proteins/metabolism , Animals , Disease Models, Animal , HEK293 Cells , Humans , Mice, Transgenic , Microdialysis , Peptide Fragments/metabolism , Phosphorylation , Protein Aggregation, Pathological/metabolism
2.
Int J Toxicol ; 40(1): 26-39, 2021.
Article in English | MEDLINE | ID: mdl-33176523

ABSTRACT

Predictive indicators of testicular toxicity could improve drug development by allowing early in-life screening for this adverse effect before it becomes severe. We hypothesized that circulating microRNAs (miRNAs) could serve as testicular toxicity biomarkers in dogs. Herein, we describe the results of an exploratory study conducted to discover biomarkers of drug-induced testicular injury. Following a dose-selection study using the testicular toxicant ethylene glycol monomethyl ether (EGME), we chose a dose of 50 mg/kg/d EGME to avoid systemic toxicity and treated 2 groups of dogs (castrated, non-castrated) for 14 to 28 days. Castrated animals were used as negative controls to identify biomarkers specific for testicular toxicity because EGME can cause toxicity to organ systems in addition to the testis. Blood was collected daily during the dosing period, followed by recovery for 29 to 43 days with less frequent sampling. Dosing was well tolerated, resulting in mild-to-moderate degeneration in testes and epididymides. Global profiling of serum miRNAs at selected dosing and recovery time points was completed by small RNA sequencing. Bioinformatics data analysis using linear modeling demonstrated several circulating miRNAs that were differentially abundant during the dosing period compared with baseline and/or castrated control samples. Confirmatory reverse transcription quantitative polymerase chain reaction data in these animals was unable to detect sustained alterations of miRNAs in serum, except for 1 potential candidate cfa-miR-146b. Taken together, we report the results of a comprehensive exploratory study and suggest future directions for follow-up research to address the challenge of developing diagnostic biomarkers of testicular toxicity.


Subject(s)
Circulating MicroRNA/drug effects , Drug Development/methods , Ethylene Glycols/toxicity , Genetic Markers/drug effects , Testis/drug effects , Animals , Disease Models, Animal , Dogs , Male
3.
Exp Toxicol Pathol ; 68(5): 289-99, 2016 May.
Article in English | MEDLINE | ID: mdl-27020044

ABSTRACT

The use of sensitive biomarkers to monitor skeletal muscle toxicity in preclinical toxicity studies is important for the risk assessment in humans during the development of a novel compound. Skeletal muscle toxicity in Sprague Dawley Rats was induced with clofibrate at different dose levels for 7 days to compare standard clinical pathology assays with novel skeletal muscle and cardiac muscle biomarkers, gene expression and histopathological changes. The standard clinical pathology assays aspartate aminotransferase (AST), alanine aminotransferase (ALT), and creatine kinase (CK) enzyme activity were compared to novel biomarkers fatty acid binding protein 3 (Fabp3), myosin light chain 3 (Myl3), muscular isoform of CK immunoreactivity (three isoforms CKBB, CKMM, CKMB), parvalbumin (Prv), skeletal troponin I (sTnI), cardiac troponin T (cTnT), cardiac troponin I (cTnI), CKMM, and myoglobin (Myo). The biomarker elevations were correlated to histopathological findings detected in several muscles and gene expression changes. Clofibrate predominantly induced skeletal muscle toxicity of type I fibers of low magnitude. Useful biomarkers for skeletal muscle toxicity were AST, Fabp3, Myl3, (CKMB) and sTnI. Measurements of CK enzyme activity by a standard clinical assay were not useful for monitoring clofibrate-induced skeletal muscle toxicity in the rat at the doses used in this study.


Subject(s)
Clofibrate/toxicity , Hypolipidemic Agents/toxicity , Muscle, Skeletal/drug effects , Alanine Transaminase/blood , Alanine Transaminase/urine , Animals , Aspartate Aminotransferases/blood , Aspartate Aminotransferases/urine , Biomarkers/blood , Biomarkers/urine , Creatine Kinase/blood , Creatine Kinase/urine , Fatty Acid Binding Protein 3 , Fatty Acid-Binding Proteins/blood , Fatty Acid-Binding Proteins/urine , Gene Expression Profiling , Heart/drug effects , Male , Muscle, Skeletal/pathology , Myocardium/pathology , Myoglobin/blood , Myosin Light Chains/blood , Myosin Light Chains/urine , Parvalbumins/blood , Parvalbumins/urine , Rats , Rats, Sprague-Dawley , Troponin C/blood , Troponin C/urine , Troponin I/blood , Troponin I/urine
4.
Toxicol Pathol ; 42(6): 997-1003, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24178576

ABSTRACT

In preclinical studies of pharmaceutical agents, the beagle dog is a commonly used model for the detection of cardiotoxicity. Incidental findings, postmortem changes, and artifacts must be distinguished histopathologically from test item-related findings in the heart. In this retrospective analysis, cardiac sections from 88 control beagles (41 male, 47 female; ages 5-18 months) in preclinical studies were examined histopathologically. The most common finding was thickening of the tunica media of intramural coronary arteries, most likely a postmortem change. The second most common finding was the presence of vacuoles within Purkinje fibers. Dilated lymphatic and blood vessels at the insertion of chordae tendineae were noted more commonly in males than in females and were considered a normal anatomic feature. Mesothelial-lined papillary fronds along the epicardial surface of the atria were present in several dogs, as were small infiltrates of inflammatory cells usually within the myocardium. In summary, control beagles' hearts frequently have incidental findings that must be differentiated from test item-related pathologic changes. Historical control data can be useful for the interpretation of incidental and test item-related findings in the beagle heart.


Subject(s)
Dog Diseases/chemically induced , Dog Diseases/pathology , Heart/drug effects , Myocardium/pathology , Animals , Control Groups , Dogs , Female , Male , Toxicity Tests/methods
5.
Toxicol Pathol ; 39(6): 980-7, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21859886

ABSTRACT

During baseline evaluation prior to a preclinical safety study, a 10-month-old male pure-bred Beagle dog was found to have marked thrombocytopenia (6 × 10(3) platelets [PLT]/µL) associated with a mean platelet volume (MPV) of 17.9 fL. Tests for Rickettsia rickettsii, Ehrlichia canis, and Borrelia burgdorferi were negative. Buccal bleeding time was normal. Over 3 months, PLT were 4 to 141 × 10(3) PLT/µL, and MPV was 11.4 to 25.1 fL; however, PLT were <50 × 10(3) PLT/µL and MPV was >16 fL during most of this period. Antinuclear antibody (ANA) and anti-PLT antibody tests were negative. Genotyping for the presence of a beta 1-tubulin mutation demonstrated the normal wild-type gene. Treatment with prednisone resulted in normal values after only 3 days. Ultrastructure of enlarged PLT was consistent with that of immature PLT, characterized by reduced numbers of peripheral microtubules and the presence of rough endoplasmic reticulum, free ribosomes, Golgi apparatus, and a prominent canalicular system. PLT ultrastructure and glucocorticoid responsiveness supported a diagnosis of immune-mediated thrombocytopenia that was masked by the cyclic nature of PLT decreases and lack of clinical signs. Inclusion of such a dog in a preclinical safety study could result in misinterpretation of clinical pathology findings.


Subject(s)
Thrombocytopenia/diagnosis , Thrombocytopenia/physiopathology , Animals , Blood Platelets/cytology , Blood Platelets/ultrastructure , Borrelia burgdorferi/isolation & purification , Dogs , Ehrlichia canis/isolation & purification , Erythrocytes/metabolism , Genotype , Glucocorticoids/metabolism , Male , Microscopy, Electron, Transmission , Platelet Count , Prednisone/therapeutic use , Rickettsia rickettsii/isolation & purification
SELECTION OF CITATIONS
SEARCH DETAIL
...